Panacos Pharmaceuticals, Inc. (PANC)
Develops oral drugs to treat HIV and viral infections.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
PANC trades at its 52-week high after climbing above both its 50- and 200-day moving averages, showing upward momentum in its recent trend. The stock is priced at $0.0001, near penny-stock territory. Analyst coverage appears unavailable for this micro-cap security.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$321,841
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—